September 8, 2021 09:04 AM EDT
Coronavirus

Covid-19 roundup: Gates Foun­da­tion, Ex­sci­en­tia team up on pan­dem­ic an­tivi­ral dis­cov­ery pact; No­vavax opens tri­al for coro­n­avirus/flu com­bo vac­cine

Kyle Blankenship

UK-based AI dis­cov­ery out­fit Ex­sci­en­tia has signed its name to a $70 mil­lion col­lab­o­ra­tion with the Bill and Melin­da Gates Foun­da­tion to drum up five …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

GSK ter­mi­nates Phase 2 tri­al of HBV ther­a­peu­tic vac­cine

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

A service from the Financial Times